Apex on stronger footing; expands pharmaceutical, consumer products


CEO of Apex Healthcare Bhd, Dr Kee Kirk Chin. - Art Chen/ The Star, 10 June 2014.

PETALING JAYA: Apex Healthcare Bhd’s transformation into a healthcare group from a pharmaceutical-based company has put it on a stronger footing in terms of revenue and earnings.

Chairman and chief executive officer Dr Kee Kirk Chin says Apex’s objective is to be an important regional player by growing the pharmaceutical, consumer products and orthopaedics business and increasing its exports.

5.5 PAYDAY OFFER: 35% OFF Digital Access

Monthly Plan

RM 13.90/month

RM 9.04/month

Billed as RM 9.04 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 8.02/month

Billed as RM 96.20 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!
Business , Corporate News , Apex Pharmacy , earnings , 7090 ,

Next In Business News

Japan's Nikkei rises on tech rally, stronger yen lifts JGBs
Indonesia to cut ride-hailing companies' maximum commission taken from drivers to 8%
Take Five: Sell in May? Let's find out
Asia shares find hope in tech resilience, oil off peak
SME Corp empowers digitalisation, automation of MSMEs
Yayasan Peneraju fast-tracks SPM leavers into chartered accountancy
ANZ says Australia likely to avoid recession; flags prolonged impact of Middle East war
Japan's factory activity growth hits 4-year high on stockpiling, PMI shows
South Korean April exports rise 48.0% y/y as chip boom extends
Japan warns yen speculators it stands ready to intervene again

Others Also Read